WHO Approves Corticosteroid Usage For Critical COVID-19 Cases

The World Health Organisation (WHO) has approved the use of corticosteroid drugs for the treatment of patients with severe and critical COVID-19.

The approval follows the trials conducted by seven researchers from Britain, Brazil, Canada, China, France, Spain and the United States, which revealed that the steroids improve survival rates of COVID-19 patients sick enough to be in intensive care in hospital.

WHO, in a statement published on Wednesday, said: “We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19.

“We suggest not to use corticosteroids in the treatment of patients with non-severe COVID-19 as the treatment brought no benefits, and could even prove harmful. Treatment should be under supervision of a clinician.

“WHO encourages countries to maintain sufficient stocks of corticosteroids to treat COVID-19 and the other disease for which they are effective, while not maintaining excessive stocks which could deny other countries access.”

“The evidence shows that if you give corticosteroids …(there are) 87 fewer deaths per 1,000 patients. Those are lives … saved,” WHO’s clinical care lead, Janet Diaz, noted.

Help Aledeh News deliver the independent journalism Nigeria and the world need. Support us by making a contribution. Your donation allows Aledeh News to be completely independent. But it also means this online platform is only possible because of the support of readers like you. Support Now!

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Bitnami banner